These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9651324)
1. Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers. Wang WQ; Merriam DL; Moses AS; Francis GA J Biol Chem; 1998 Jul; 273(28):17391-8. PubMed ID: 9651324 [TBL] [Abstract][Full Text] [Related]
2. Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers. Wang WQ; Moses AS; Francis GA Biochemistry; 2001 Mar; 40(12):3666-73. PubMed ID: 11297434 [TBL] [Abstract][Full Text] [Related]
3. Determination of myeloperoxidase-induced apoAI-apoAII heterodimers in high-density lipoprotein. Kameda T; Usami Y; Shimada S; Haraguchi G; Matsuda K; Sugano M; Kurihara Y; Isobe M; Tozuka M Ann Clin Lab Sci; 2012; 42(4):384-91. PubMed ID: 23090734 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525 [TBL] [Abstract][Full Text] [Related]
5. Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. Garner B; Waldeck AR; Witting PK; Rye KA; Stocker R J Biol Chem; 1998 Mar; 273(11):6088-95. PubMed ID: 9497326 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein AI efficiently binds to and mediates cholesterol and phospholipid efflux from human but not rat aortic smooth muscle cells. Francis GA; Tsujita M; Terry TL Biochemistry; 1999 Dec; 38(49):16315-22. PubMed ID: 10587456 [TBL] [Abstract][Full Text] [Related]
7. Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol. Garner B; Witting PK; Waldeck AR; Christison JK; Raftery M; Stocker R J Biol Chem; 1998 Mar; 273(11):6080-7. PubMed ID: 9497325 [TBL] [Abstract][Full Text] [Related]
9. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. Francis GA; Mendez AJ; Bierman EL; Heinecke JW Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6631-5. PubMed ID: 8341680 [TBL] [Abstract][Full Text] [Related]
10. Administration of tyrosyl radical-oxidized HDL inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Macdonald DL; Terry TL; Agellon LB; Nation PN; Francis GA Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1583-8. PubMed ID: 12855483 [TBL] [Abstract][Full Text] [Related]
11. Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption. Francis GA; Oram JF; Heinecke JW; Bierman EL Biochemistry; 1996 Dec; 35(48):15188-97. PubMed ID: 8952466 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles. Lund-Katz S; Murley YM; Yon E; Gillotte KL; Davidson WS Lipids; 1996 Nov; 31(11):1107-13. PubMed ID: 8934442 [TBL] [Abstract][Full Text] [Related]
13. Lipid-bound apolipoproteins in tyrosyl radical-oxidized HDL stabilize ABCA1 like lipid-free apolipoprotein A-I. Hossain MA; Ngeth S; Chan T; Oda MN; Francis GA BMC Biochem; 2012 Jan; 13():1. PubMed ID: 22248050 [TBL] [Abstract][Full Text] [Related]
14. Spectrum of Apolipoprotein AI and Apolipoprotein AII Proteoforms and Their Associations With Indices of Cardiometabolic Health: The CARDIA Study. Wilkins JT; Seckler HS; Rink J; Compton PD; Fornelli L; Thaxton CS; LeDuc R; Jacobs D; Doubleday PF; Sniderman A; Lloyd-Jones DM; Kelleher NL J Am Heart Assoc; 2021 Sep; 10(17):e019890. PubMed ID: 34472376 [TBL] [Abstract][Full Text] [Related]
15. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport. Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein AII enrichment of HDL enhances their affinity for class B type I scavenger receptor but inhibits specific cholesteryl ester uptake. Pilon A; Briand O; Lestavel S; Copin C; Majd Z; Fruchart JC; Castro G; Clavey V Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1074-81. PubMed ID: 10764676 [TBL] [Abstract][Full Text] [Related]
19. Role of the carboxy-terminal domain of human apolipoprotein AI in high-density-lipoprotein metabolism--a study based on deletion and substitution variants in transgenic mice. Holvoet P; Danloy S; Collen D Eur J Biochem; 1997 May; 245(3):642-7. PubMed ID: 9183000 [TBL] [Abstract][Full Text] [Related]
20. Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits. Koike T; Koike Y; Yang D; Guo Y; Rom O; Song J; Xu J; Chen Y; Wang Y; Zhu T; Garcia-Barrio MT; Fan J; Chen YE; Zhang J Atherosclerosis; 2021 Jan; 316():32-40. PubMed ID: 33296791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]